This Workstream was formed in 2021 to expand the PVRI community’s awareness and understanding of emerging device technologies for treating and diagnosing PH and RHF. It comprises experienced colleagues from academia, pharma, and regulatory fields, each with expertise in drug, device, and combination development.
Members aim to innovate and change current thinking, working in three sub-teams:
Targeted pulmonary delivery (Inhalation), led by Nicholas Hill and Peter Fernandes
Treatment (Therapeutic), led by Marc Pritzker and John Scandurra
Monitoring (Diagnosis), led by Harry Rowland and Alex Rothman
The Workstream is currently working on two manuscripts:
Inhalation technology advancements in treating RHF and PH
Advancements in the use of devices to treat PH
The group meets on the second Friday of each month at 15:00 BST.
